FDA Clears IND Application for Passage Bio’s Gene Therapy Candidate PBKR03 for Treatment of Patients with Early Infantile Krabbe Disease, A Rare Pediatric Disorder with No Approved Disease-Modifying
Go back to FDA Clears IND Application for Passage Bio’s Gene Therapy Candidate PBKR03 for Treatment of Patients with Early Infantile Krabbe Disease, A Rare Pediatric Disorder with No Approved Disease-Modifying(NASDAQ: PASG) | Delayed: 1.27 +0.03 (2.42%) | |||||
---|---|---|---|---|---|---|
Previous Close | $1.24 | 52 Week High | $ | |||
Open | $1.24 | 52 Week Low | $ | |||
Day High | $1.30 | P/E | N/A | |||
Day Low | $1.23 | EPS | $ | |||
Volume | 59,173 |
(NASDAQ: PASG) | Delayed: 1.27 +0.03 (2.42%) | |||||
---|---|---|---|---|---|---|
Previous Close | $1.24 | 52 Week High | $ | |||
Open | $1.24 | 52 Week Low | $ | |||
Day High | $1.30 | P/E | N/A | |||
Day Low | $1.23 | EPS | $ | |||
Volume | 59,173 |